| Public Health and Environmental Issues | Lifetime | 1 | PE 1 | 99.71 |
| Health and Medical Education | Lifetime | 6 | PE 1 | 99.43 |
| COVID-19 Clinical Research Studies | Lifetime | 88 | PE 1 | 99.41 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 134 | PE 1 | 99.36 |
| Zoonotic diseases and public health | Lifetime | 37 | PE 1 | 99.13 |
| COVID-19 epidemiological studies | Lifetime | 82 | PE 1 | 99.10 |
| Mosquito-borne diseases and control | Lifetime | 179 | PE 1 | 99.31 |
| Long-Term Effects of COVID-19 | Lifetime | 232 | PE 1 | 97.89 |
| Viral Infections and Vectors | Lifetime | 309 | PE 1 | 98.92 |
| Poxvirus research and outbreaks | Lifetime | 53 | PE 1 | 98.23 |
| Bacillus and Francisella bacterial research | Lifetime | 83 | PE 1 | 97.94 |
| COVID-19 Pandemic Impacts | Lifetime | 124 | PE 1 | 96.90 |
| Educational Research and Science Teaching | Lifetime | 45 | PE 3 | 98.04 |
| Viral Infections and Outbreaks Research | Lifetime | 238 | PE 1 | 97.70 |
| Travel-related health issues | Lifetime | 66 | PE 1 | 97.36 |
| Public Health and Social Inequalities | Lifetime | 53 | PE 3 | 96.18 |
| Vaccine Coverage and Hesitancy | Lifetime | 494 | PE 1 | 96.79 |
| Health and Medical Research Impacts | Lifetime | 301 | PE 1 | 93.89 |
| Parasites and Host Interactions | Lifetime | 751 | PE 2 | 95.84 |
| Dermatological diseases and infestations | Lifetime | 192 | PE 1 | 94.44 |
| COVID-19 Impact on Reproduction | Lifetime | 432 | PE 1 | 92.04 |
| COVID-19 diagnosis using AI | Lifetime | 525 | PE 1 | 92.31 |
| Trypanosoma species research and implications | Lifetime | 951 | PE 4 | 94.90 |
| SARS-CoV-2 detection and testing | Lifetime | 746 | PE 1 | 91.09 |
| Psychology Research and Bibliometrics | Lifetime | 191 | PE 7 | 92.11 |
| Brucella: diagnosis, epidemiology, treatment | Lifetime | 736 | PE 4 | 85.48 |
| Dengue and Mosquito Control Research | Lifetime | 813 | PE 3 | 79.73 |
| Leptospirosis research and findings | Lifetime | 971 | PE 3 | 79.58 |
| Global Health and Epidemiology | Lifetime | 630 | PE 2 | 67.12 |
| Gender, Health, and Social Inequality | Lifetime | 360 | PE 14 | 56.04 |
| Beetle Biology and Toxicology Studies | Lifetime | 992 | PE 1 | 39.23 |
| Mosquito-borne diseases and control | 2021-2025 | 6 | PE 1 | 99.64 |
| Poxvirus research and outbreaks | 2021-2025 | 1 | PE 1 | 99.64 |
| Herpesvirus Infections and Treatments | 2021-2025 | 3 | PE 1 | 99.16 |
| Bacillus and Francisella bacterial research | 2021-2025 | 2 | PE 1 | 99.39 |
| Viral Infections and Vectors | 2021-2025 | 13 | PE 1 | 99.34 |
| Viral Infections and Outbreaks Research | 2021-2025 | 14 | PE 1 | 98.71 |
| Zoonotic diseases and public health | 2021-2025 | 17 | PE 1 | 98.24 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 253 | PE 1 | 98.88 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 89 | PE 1 | 98.29 |
| COVID-19 Clinical Research Studies | 2021-2025 | 492 | PE 1 | 97.75 |
| COVID-19 epidemiological studies | 2021-2025 | 182 | PE 1 | 97.23 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 205 | PE 1 | 95.53 |
| Vector-Borne Animal Diseases | 2021-2025 | 75 | PE 1 | 96.09 |
| Public Health and Environmental Issues | 2021-2025 | 14 | PE 5 | 90.81 |
| COVID-19 Pandemic Impacts | 2021-2025 | 341 | PE 1 | 90.60 |
| Dermatological diseases and infestations | 2021-2025 | 50 | PE 1 | 89.16 |
| SARS-CoV-2 detection and testing | 2021-2025 | 797 | PE 1 | 88.52 |
| Rabies epidemiology and control | 2021-2025 | 154 | PE 1 | 89.01 |
| COVID-19 Impact on Reproduction | 2021-2025 | 588 | PE 1 | 85.87 |
| Animal Disease Management and Epidemiology | 2021-2025 | 658 | PE 1 | 86.96 |
| Influenza Virus Research Studies | 2021-2025 | 756 | PE 1 | 86.82 |
| Virology and Viral Diseases | 2021-2025 | 344 | PE 1 | 81.41 |
| Parasites and Host Interactions | 2021-2025 | 690 | PE 3 | 82.21 |
| Yersinia bacterium, plague, ectoparasites research | 2021-2025 | 406 | PE 1 | 72.29 |
| Leptospirosis research and findings | 2021-2025 | 182 | PE 1 | 74.35 |
| Travel-related health issues | 2021-2025 | 267 | PE 1 | 64.37 |
| Insects and Parasite Interactions | 2021-2025 | 256 | PE 1 | 54.21 |
| Dermatological and COVID-19 studies | 2021-2025 | 745 | PE 4 | 50.74 |
| Parasitic Diseases Research and Treatment | 2021-2025 | 961 | PE 7 | 44.84 |
